Free Trial

Craneware (LON:CRW) Trading Up 8.2% Following Dividend Announcement

Craneware logo with Medical background

Craneware plc (LON:CRW - Get Free Report)'s share price was up 8.2% during mid-day trading on Tuesday following a dividend announcement from the company. The stock traded as high as GBX 2,300 ($30.24) and last traded at GBX 2,239 ($29.44). Approximately 304,186 shares changed hands during mid-day trading, an increase of 302% from the average daily volume of 75,699 shares. The stock had previously closed at GBX 2,070 ($27.22).

The newly announced dividend which will be paid on Wednesday, December 18th. Shareholders of record on Thursday, November 28th will be issued a GBX 16 ($0.21) dividend. The ex-dividend date is Thursday, November 28th. This represents a yield of 0.77%. This is a boost from Craneware's previous dividend of $13.00. Craneware's dividend payout ratio (DPR) is currently 14,500.00%.

Analysts Set New Price Targets

Separately, Berenberg Bank reaffirmed a "buy" rating and set a GBX 2,700 ($35.50) target price on shares of Craneware in a report on Tuesday.

View Our Latest Stock Analysis on Craneware

Craneware Price Performance

The company has a market capitalization of £787.64 million, a P/E ratio of 11,150.00 and a beta of 0.37. The company has a quick ratio of 1.00, a current ratio of 0.78 and a debt-to-equity ratio of 19.15. The business has a 50 day simple moving average of GBX 2,323.68 and a 200-day simple moving average of GBX 2,263.13.

Craneware Company Profile

(Get Free Report)

Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States. The company provides solutions, such as Trisus pricing transparency software; Trisus Pricing Analyzer, a solution that simplifies and automates the price modeling process; Trisus Chargemaster, an automated chargemaster management solution; InSight Medical Necessity, a solution that offers medical necessity for the United States payors; Trisus Claims Informatics, a retrospective charge capture analytical application that identifies areas of risk for its team to investigate; Trisus Supply, a solution that improves supplies reimbursement; and InSight Audit, an audit management solution for government and commercial payors.

Recommended Stories

→ Forget Trump and Kamala (From Investors Alley) (Ad)

Should you invest $1,000 in Craneware right now?

Before you consider Craneware, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Craneware wasn't on the list.

While Craneware currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Is Palantir Heading for a $50 Price Target?
Rate Cuts Fuel Volatility: How Long Could it Last?
SMCI Stock: Is a Rebound Coming?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines